Table 2.

Analysis by type of cancer: observed numbers of people with NMSC who had a subsequent record of primary malignant cancer, RRs and 95% CIs

Cancer following admission for NMSC
Site (ICD–10 code)ORR (95% CI)
Any malignant primary cancer excluding NMSCa67,1481.36 (1.35–1.37)
Any malignant primary cancer excluding all skinb62,3771.27 (1.26–1.28)
Bladder (C67)5,3721.13 (1.10–1.16)
Bone (C40–C41)5542.93 (2.66–3.23)
Brain (C71)7811.07 (1.00–1.16)
Breast (C50)6,1541.24 (1.21–1.28)
Cervix (C53)1930.97 (0.83–1.12)
Colon (C18–C19)7,2591.16 (1.13–1.19)
GI—upper (C00–C06.8, C09–C10, and C12–C14)1,9742.36 (2.25–2.48)
Kidney (C64–C65)1,9091.18 (1.13–1.24)
Larynx (C32)6491.32 (1.21–1.43)
Leukemia—lymphoid (C91)2,0962.01 (1.92–2.11)
Leukemia—myeloid (C92)1,1731.28 (1.21–1.37)
Liver (C22)1,0951.10 (1.03–1.17)
Lung (C33–C34)10,9421.31 (1.28–1.33)
Lymphoma—Hodgkins (C81)2981.68 (1.48–1.89)
Lymphoma—non-Hodgkins (C82–C85)3,6321.63 (1.58–1.69)
Melanoma—malignant (C43)6,6935.54 (5.37–5.71)
Multiple myeloma (C90)1,2251.13 (1.07–1.20)
Nasopharynx (C11)981.48 (1.19–1.82)
Nervous system—other (C70)621.91 (1.43–2.51)
Esophageal (C15)2,2741.10 (1.06–1.15)
Ovary (C56)8981.08 (1.01–1.16)
Pancreas (C25)1,9751.05 (1.00–1.10)
Prostate (C61)11,7301.12 (1.10–1.14)
Rectum (C20–C21)3,5291.43 (1.38–1.48)
Salivary gland (C07–C08)8815.78 (5.29–6.32)
Stomach (C16)2,2051.08 (1.04–1.13)
Testis (C62)691.28 (0.99–1.62)
Thyroid (C73)2261.25 (1.08–1.43)
Uterus—body of (C54)8301.05 (0.98–1.13)

NOTE: All these ICD codes are specifically for primary malignancy.

  • aC00–C43, C45–C75, and C81–C97.

  • bC00–C41, C45–C75, and C81–C97.